Sanofi SA vs Uranium Energy Corp — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Uranium Energy Corp trades at $9.6 (market cap $4.65B). The key difference: Sanofi SA is far larger — about 22.5× Uranium Energy Corp's market cap, and Sanofi SA pays a 5.5% dividend while Uranium Energy Corp pays none. Which is the better fit depends on your goals.
| SNY | UEC | |
|---|---|---|
Market Cap | $104.83B | $4.65B |
Sector | Health | Energy |
52-Week High | $52.34 | $20.14 |
52-Week Low | $41.33 | $8.00 |
Enterprise Value | $121.32B | $4.16B |
Dividend Yield | 5.5% | — |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.
Read more on UEC →